Recommended Dosage
1-2 tablets two times a day orally after meals or as directed by the physician
Standardised Extract
FDA Approved
Doctors Recommended
Stability Tested
Pharmacological Evaluation of Hepatoprotective Activity of Ariliv Tablet (AHPL/AYTAB/0613 Tablet) in Carbon Tetrachloride‑, Ethanol‑, and Paracetamol‑Induced Hepatotoxicity Models
Pharmacological Evaluation of Hepatoprotective Activity of Ariliv Tablet (AHPL/AYTAB/0613 Tablet) in Carbon Tetrachloride‑, Ethanol‑, and Paracetamol‑Induced Hepatotoxicity Models
1-2 tablets two times a day orally after meals or as directed by the physician
Caution
Do not consume if allergic to any ingredient | Consult your physician for relevant dosage | Do not exceed the recommended daily dose | Contraindicated in pregnant and lactating women | This product is not intended to diagnose, treat, cure, prevent any disease, or for medicinal use | Store in a cool, dry place away from direct sunlight | Keep out of reach of children.
Product Type: Tablet
Country of Origin: India
Manufactured By: Ari Healthcare Pvt. Ltd. At: 34/7, Erandwana, Erandwana, Pune-411004